Use of Molecular Genetic Testing in MDS and MPN

Earn CME for related activities: www.naccme.com...
In this presentation from the 2019 Great Debates & Updates in Hematologic Malignancies - Los Angeles, held from March 22-23, Dr. Amer M. Zeidan discusses the use of molecular testing in the treatment of myeloproliferative neoplasms (MPN) and myelodysplastic syndromes (MDS).
© 2019 Imedex, an HMP Company